Fangjia Tong

544 total citations
17 papers, 396 citations indexed

About

Fangjia Tong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fangjia Tong has authored 17 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Fangjia Tong's work include Cancer-related molecular mechanisms research (6 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). Fangjia Tong is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Extracellular vesicles in disease (4 papers) and MicroRNA in disease regulation (4 papers). Fangjia Tong collaborates with scholars based in China, United States and Taiwan. Fangjia Tong's co-authors include Lanlan Wei, Bingqing Yan, Xionghui Mao, Bozhi Wang, Ji Sun, Huanhuan Xie, Siwei Zhang, Xiaohang Chen, Fengmin Zhang and Xiaowei Wang and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Cancer Letters.

In The Last Decade

Fangjia Tong

16 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangjia Tong China 11 220 171 126 122 83 17 396
Makiko Moriyama‐Kita Japan 12 172 0.8× 105 0.6× 161 1.3× 62 0.5× 61 0.7× 28 353
Thomas Brunhuber Austria 6 179 0.8× 78 0.5× 217 1.7× 33 0.3× 59 0.7× 10 433
Takeshi Kuroshima Japan 10 239 1.1× 105 0.6× 91 0.7× 20 0.2× 61 0.7× 37 385
Evangelia Michailidou Greece 8 143 0.7× 88 0.5× 35 0.3× 59 0.5× 52 0.6× 13 361
Christina A. Marsh United States 6 214 1.0× 57 0.3× 141 1.1× 36 0.3× 39 0.5× 7 331
Brian Lane United Kingdom 9 160 0.7× 64 0.4× 98 0.8× 27 0.2× 30 0.4× 14 330
Touraj Taheri Australia 8 86 0.4× 46 0.3× 72 0.6× 34 0.3× 36 0.4× 20 213
Nadine C. Olthof Netherlands 8 130 0.6× 120 0.7× 138 1.1× 19 0.2× 246 3.0× 8 431
Andrew Sewell United States 6 125 0.6× 72 0.4× 90 0.7× 23 0.2× 83 1.0× 9 288
Mattias Jangard Sweden 9 98 0.4× 22 0.1× 180 1.4× 81 0.7× 68 0.8× 15 323

Countries citing papers authored by Fangjia Tong

Since Specialization
Citations

This map shows the geographic impact of Fangjia Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangjia Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangjia Tong more than expected).

Fields of papers citing papers by Fangjia Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangjia Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangjia Tong. The network helps show where Fangjia Tong may publish in the future.

Co-authorship network of co-authors of Fangjia Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Fangjia Tong. A scholar is included among the top collaborators of Fangjia Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangjia Tong. Fangjia Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Scholten, David, Lamiaa El-Shennawy, Yuzhi Jia, et al.. (2025). Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis. Journal of Clinical Investigation. 135(18). 1 indexed citations
2.
Zhang, Shengkun, Dapeng Li, Yijie Wang, et al.. (2024). Comparative study of pathogen detection methods for central nervous system infections: laboratory testing of tuberculous meningitis. BMC Infectious Diseases. 24(1). 1172–1172.
3.
Tong, Fangjia, Gongyu Tang, & Xiaowei Wang. (2023). Characteristics of Human and Microbiome RNA Profiles in Saliva. RNA Biology. 20(1). 398–408. 5 indexed citations
4.
Mehrad, Mitra, Kim Ely, Fangjia Tong, et al.. (2023). Sinonasal Adenosquamous Carcinoma - Morphology and Genetic Drivers Including Low- and High-Risk Human Papillomavirus mRNA, DEK::AFF2 Fusion, and MAML2 Rearrangement. Head and Neck Pathology. 17(2). 487–497. 8 indexed citations
5.
Wang, Bozhi, et al.. (2022). HPV+ HNSCC‐derived exosomal miR‐9‐5p inhibits TGF‐β signaling‐mediated fibroblast phenotypic transformation through NOX4. Cancer Science. 113(4). 1475–1487. 26 indexed citations
6.
Lewis, James S., et al.. (2022). Human Papillomavirus-Associated Oral Cavity Squamous Cell Carcinoma: An Entity with Distinct Morphologic and Clinical Features. Head and Neck Pathology. 16(4). 1073–1081. 13 indexed citations
7.
Yang, Jing, Huashan Wang, Edith A. Perez, et al.. (2022). Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10. Cancer Letters. 555. 216025–216025. 7 indexed citations
8.
Wang, Bozhi, Fen Ma, Fangjia Tong, et al.. (2021). Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma. Cancer Science. 112(4). 1402–1416. 27 indexed citations
9.
Tong, Fangjia, et al.. (2020). Comprehensive profiling of extracellular RNA in HPV-induced cancers using an improved pipeline for small RNA-seq analysis. Scientific Reports. 10(1). 19450–19450. 22 indexed citations
10.
Tong, Fangjia, Xionghui Mao, Siwei Zhang, et al.. (2020). HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity. Cancer Letters. 478. 34–44. 88 indexed citations
11.
Song, Lianhao, Huanhuan Xie, Fangjia Tong, et al.. (2019). Association of lnc‐IL17RA‐11 with increased radiation sensitivity and improved prognosis of HPV‐positive HNSCC. Journal of Cellular Biochemistry. 120(10). 17438–17448. 17 indexed citations
12.
Mao, Xionghui, et al.. (2019). IL-6 induced M1 type macrophage polarization increases radiosensitivity in HPV positive head and neck cancer. Cancer Letters. 456. 69–79. 54 indexed citations
13.
Yan, Bingqing, Xinyi Liu, Siwei Zhang, et al.. (2019). DisV-HPV16, versatile and powerful software to detect HPV in RNA sequencing data. BMC Infectious Diseases. 19(1). 479–479. 1 indexed citations
14.
Tong, Fangjia, Jingshu Geng, Bingqing Yan, et al.. (2018). Prevalence and Prognostic Significance of HPV in Laryngeal Squamous Cell Carcinoma in Northeast China. Cellular Physiology and Biochemistry. 49(1). 206–216. 22 indexed citations
15.
Meng, Hongxue, Susheng Miao, Kexin Chen, et al.. (2018). Association of p16 as Prognostic Factors for Oropharyngeal Cancer: Evaluation of p16 in 1470 Patients for a 16 Year Study in Northeast China. BioMed Research International. 2018. 1–8. 26 indexed citations
16.
Chen, Xiaohang, Bingqing Yan, Fangjia Tong, et al.. (2018). Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis. Molecular Immunology. 96. 28–36. 64 indexed citations
17.
Li, Jinyuan, Libo Yu, Yushu Li, et al.. (2016). miR-34a and its novel target, NLRC5, are associated with HPV16 persistence. Infection Genetics and Evolution. 44. 293–299. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026